Breaking News Instant updates and real-time market news.

AMRN

Amarin

$15.45

1.52 (10.91%)

14:38
01/09/19
01/09
14:38
01/09/19
14:38

Amarin CEO hints at stronger 2019 outlook for Vascepa sales, STAT News reports

Amarin CEO John Thero dropped hints at his breakout session at the JPMorgan Healthcare conference that the comapny has a stronger 2019 outlook for Vascepa than its official guidance offered a week ago, STAT News reports. Though Thero can't say directly that he expects better sales, he not-so-subtly suggested a stronger sales outlook for the heart drug, the report says. Reference Link

  • 09

    Jan

AMRN Amarin
$15.45

1.52 (10.91%)

12/20/18
JEFF
12/20/18
NO CHANGE
Target $30
JEFF
Buy
Amarin shares will bounce back on 2019 catalysts, says Jefferies
After hosting meetings with management, Jefferies analyst Michael Yee says Amarin represents one of the few "de-risked" standalone blockbuster drugs in the smid-cap Biotech space. Following the stock's pullback from of $23 to $15, Amarin will "bounce and go back up," predicts the analyst. He sees 2019 catalysts from "scripts and sales ramp to FDA approval." Further, a potential takeout is a "wildcard," writes Yee in a note titled "The Big Fish In A Big Pond? Update from Mgmt Meetings..." The analyst keeps a Buy rating on Amarin with a $30 price target.
01/07/19
RHCO
01/07/19
NO CHANGE
Target $15
RHCO
Buy
Amarin price target lowered to $15 from $30 at SunTrust
SunTrust analyst John Boris lowered his price target on Amarin after the company guided its FY19 revenue outlook well below consensus and offered more details timing of Vascepa sNDA filing. The analyst contends that the company needs to employ a larger sales force to "realize Vascepa full potential" beyond the 400 reps currently and also lowers his FY19 EPS view to (23c) from 18c to reflect Amarin's expectations of lower sales and higher SG&A costs. Longer term, Boris keeps his Buy rating on Amarin, noting that Vascepa could have a "significant commercial upside" if it can secure a label for reducing cardiovascular risk.
01/07/19
JEFF
01/07/19
NO CHANGE
Target $30
JEFF
Buy
Jefferies keeps $30 target on Amarin, says guidance conservative
Amarin Friday night reported "strong" Q4 Vascepa results, although stock is trading lower perhaps due to conservative guidance, Jefferies analyst Michael Yee tells investors in a research note. The analyst views the news "as a positive sign of what's been going on recently." Amarin does not even have a label expansion yet and it has been only two months since the mid-November data presentation, Yee writes. He expects trends to continue to grow monthly throughout the year, even before Amarin receives a formal label expansion. While the stock may be down today, "things look strong fundamentally," Yee contends. He views the company's sales guidance as conservative and keeps a Buy rating on Amarin with a $30 price target.
01/08/19
SBSH
01/08/19
NO CHANGE
Target $20
SBSH
Buy
Amarin price target lowered to $20 from $28 at Citi
Citi analyst Joel Beatty lowered his price target for Amarin to $20 after the company's 2019 revenue guidance came in lower than he expected. The analyst, however, continues to view Vascepa as an "attractive and differentiated cardiovascular risk reduction therapy." His peak sales estimate is now $2.5B, down from $3.0B previously.

TODAY'S FREE FLY STORIES

ALXN

Alexion

$127.56

-2.17 (-1.67%)

07:12
02/22/19
02/22
07:12
02/22/19
07:12
Initiation
Alexion initiated  »

Alexion initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

MCRB

Seres Therapeutics

$5.83

-0.07 (-1.19%)

07:11
02/22/19
02/22
07:11
02/22/19
07:11
Initiation
Seres Therapeutics initiated  »

Seres Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

  • 18

    May

TREE

LendingTree

$310.22

-4.78 (-1.52%)

07:11
02/22/19
02/22
07:11
02/22/19
07:11
Recommendations
LendingTree analyst commentary  »

LendingTree price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 14

    Mar

  • 19

    Mar

ANAB

AnaptysBio

$64.87

-0.12 (-0.18%)

07:11
02/22/19
02/22
07:11
02/22/19
07:11
Initiation
AnaptysBio initiated  »

AnaptysBio initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$88.80

0.35 (0.40%)

07:10
02/22/19
02/22
07:10
02/22/19
07:10
Hot Stocks
United Airlines names Robert Rivkin as SVP and General Counsel »

United Airlines named…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

RUTH

Ruth's Hospitality

$25.01

0.35 (1.42%)

07:09
02/22/19
02/22
07:09
02/22/19
07:09
Hot Stocks
Ruth's Hospitality raises quarterly dividend to 13c per share »

Subsequent to the end of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

MYGN

Myriad Genetics

$31.73

-0.19 (-0.60%)

07:09
02/22/19
02/22
07:09
02/22/19
07:09
Hot Stocks
Myriad Genetics announces Vectra study data published »

Myriad Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 11

    Mar

INTU

Intuit

$234.85

-1.06 (-0.45%)

07:09
02/22/19
02/22
07:09
02/22/19
07:09
Recommendations
Intuit analyst commentary  »

Intuit price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

FAMI

Farmmi

$3.07

-0.04 (-1.29%)

07:09
02/22/19
02/22
07:09
02/22/19
07:09
Hot Stocks
Farmmi, Fenghengda Food enter cooperation agreement »

Farmmi announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TYL

Tyler Technologies

$208.83

-4.36 (-2.05%)

07:09
02/22/19
02/22
07:09
02/22/19
07:09
Downgrade
Tyler Technologies rating change  »

Tyler Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

TROX

Tronox

$11.35

(0.00%)

07:08
02/22/19
02/22
07:08
02/22/19
07:08
Recommendations
Tronox analyst commentary  »

Tronox shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

LX

LexinFintech

$10.32

0.03 (0.29%)

07:08
02/22/19
02/22
07:08
02/22/19
07:08
Hot Stocks
LexinFintech names Shirley Yang as Chief Human Resources Officer »

LexinFintech announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$117.14

-0.87 (-0.74%)

07:08
02/22/19
02/22
07:08
02/22/19
07:08
Hot Stocks
Wayfair reports 15.2M active customers, up 37.9% year-over-year »

The number of active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 03

    Mar

CRM

Salesforce

$159.66

1.12 (0.71%)

07:08
02/22/19
02/22
07:08
02/22/19
07:08
Recommendations
Salesforce analyst commentary  »

Oppenheimer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

  • 03

    Mar

  • 04

    Mar

RUTH

Ruth's Hospitality

$25.01

0.35 (1.42%)

07:07
02/22/19
02/22
07:07
02/22/19
07:07
Earnings
Ruth's Hospitality reports Q4 EPS ex-items 50c, consensus 49c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

SRE

Sempra Energy

$117.67

0.5 (0.43%)

07:06
02/22/19
02/22
07:06
02/22/19
07:06
Hot Stocks
Sempra Energy raises annual dividend 8.1% to $3.87 per share »

Sempra Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

W

Wayfair

$117.14

-0.87 (-0.74%)

07:05
02/22/19
02/22
07:05
02/22/19
07:05
Earnings
Wayfair reports Q4 adjusted EPS ($1.12), consensus (1.28) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 03

    Mar

FIVE

Five Below

$129.64

-1.05 (-0.80%)

07:05
02/22/19
02/22
07:05
02/22/19
07:05
Downgrade
Five Below rating change  »

JPMorgan downgrades Five…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AN

AutoNation

$38.37

-0.76 (-1.94%)

07:04
02/22/19
02/22
07:04
02/22/19
07:04
Hot Stocks
AutoNation reports Q4 same-store revenue $5.3B vs. $5.5B a year ago »

Same-store fourth quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 27

    Feb

SPY

SPDR S&P 500 ETF Trust

$277.43

-0.99 (-0.36%)

, SPX

S&P 500

$0.00

(0.00%)

07:04
02/22/19
02/22
07:04
02/22/19
07:04
Periodicals
U.S pinning trade hopes on China's special envoy Liu He, WSJ says »

As the March 1 trade…

SPY

SPDR S&P 500 ETF Trust

$277.43

-0.99 (-0.36%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AN

AutoNation

$38.37

-0.76 (-1.94%)

07:03
02/22/19
02/22
07:03
02/22/19
07:03
Hot Stocks
AutoNation announces regional restructuring and cost savings plan »

AutoNation previously…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 27

    Feb

SBAC

SBA Communications

$182.45

-0.57 (-0.31%)

07:03
02/22/19
02/22
07:03
02/22/19
07:03
Downgrade
SBA Communications rating change  »

Guggenheim downgrades SBA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 11

    Mar

AN

AutoNation

$38.37

-0.76 (-1.94%)

07:02
02/22/19
02/22
07:02
02/22/19
07:02
Hot Stocks
AutoNation names Carl Liebert as new CEO and President »

AutoNation announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 27

    Feb

EADSY

Airbus

$0.00

(0.00%)

, BA

Boeing

$417.48

-4.13 (-0.98%)

07:02
02/22/19
02/22
07:02
02/22/19
07:02
Periodicals
Airbus pushes Indian budget carriers towards widebody operations, Reuters says »

Airbus (EADSY) has been…

EADSY

Airbus

$0.00

(0.00%)

BA

Boeing

$417.48

-4.13 (-0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 11

    Mar

  • 28

    May

AN

AutoNation

$38.37

-0.76 (-1.94%)

07:01
02/22/19
02/22
07:01
02/22/19
07:01
Hot Stocks
Breaking Hot Stocks news story on AutoNation »

AutoNation announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 27

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.